Engrail Therapeutics Raises $157M to Pioneer Neuroscientific Innovations
Engrail Therapeutics Raises $157M to Pioneer Neuroscientific Innovations, Engrail Therapeutics, has successfully raised $157 million in its Series B funding round. The funding was co-led by F-Prime Capital, Forbion, and Norwest Venture Partners, with participation from other notable investors including…